(Q47577493)

4 February 2018

title

Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling (English)

1 reference

4 February 2018

Lacey Johnson

2

0 references

Denese C Marks

object named as

Denese C Marks

series ordinal

4

0 references

author name string

Samantha Reid

series ordinal

1

1 reference

4 February 2018

Narelle Woodland

series ordinal

3

1 reference

4 February 2018

publication date

10 February 2012

1 reference

4 February 2018

published in

Transfusion

1 reference

4 February 2018

volume

52

1 reference

4 February 2018

issue

10

1 reference

4 February 2018

page(s)

2094-2103

1 reference

4 February 2018

Modeling the risk of an emerging pathogen entering the Canadian blood supply

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Bcl-2-regulated apoptosis: mechanism and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Deadly splicing: Bax becomes Almighty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

How the Bcl-2 family of proteins interact to regulate apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Platelet senescence is regulated by an internal timer, not damage inflicted by hits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Programmed anuclear cell death delimits platelet life span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

An intracellular wave of cytochrome c propagates and precedes Bax redistribution during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Caspases: intracellular signaling by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Caspase inhibition decreases both platelet phosphatidylserine exposure and aggregation: caspase inhibition of platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

Platelet senescence and phosphatidylserine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03558.X

10.1111/J.1537-2995.2011.03558.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018